KHRN.H — Khiron Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Annual balance sheet for Khiron Life Sciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2017 May 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.005	19	36.7	8.17	8.92
Net Total Accounts Receivable
Net Total Receivables	—	4.17	4.24	4.58	2.88
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.009	23.9	44.8	36.4	23.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	9.62	15.9	17.5	13.6
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	0.009	40.3	81.9	73.2	42.3
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.117	6.6	8.44	7.34	7.72
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	0.117	14.8	11.9	9.95	8.95
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	-0.108	25.5	70	63.2	33.3
Total Liabilities & Shareholders' Equity	0.009	40.3	81.9	73.2	42.3
Total Common Shares Outstanding